Rapid screening of specific changes in mRNA in thyroid carcinomas by sequence specific-differential display: Decreased expression of acid ceramidase mRNA in malignant and benign thyroid tumors

International Journal of Cancer

Volumn 81, Issue 5, 1999, Pages 700-704

  Maeda, Ikuhiro ^a   Takano, Toru ^b   Matsuzuka, Fumio ^c   Maruyama, Tokuyoshi ^d   Higashiyama, Takuya ^b   Liu, Gang ^b   Kuma, Kanji ^c   Amino, Nobuyuki ^b  

^a OSAKA UNIVERSITY HOSPITAL   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c KUMA HOSPITAL   (Japan)

^d MIE UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; COMPLEMENTARY DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA;

ANAPLASTIC CARCINOMA; ARTICLE; BENIGN TUMOR; CANCER SCREENING; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; GOITER; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR CLONING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR;

ADENOMA; AMIDOHYDROLASES; BLOTTING, NORTHERN; CARCINOMA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC SCREENING; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; GOITER; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID GLAND; THYROID NEOPLASMS;

EID: 0032959112     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990531)81:5<700::AID-IJC5>3.0.CO;2-D     Document Type: Article

References (23)

1. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
2. DUMONT, J.E., LAMY, F., ROGER, P. and MAENHAUT, C., Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev., 72, 667-697 (1992).
3. FRANK, S., VON SPECHT, B.U., FARTHMANN, E.H. and HIRSCH, T., Identification of genes involved in human mesothelial cancer progression using a modified differential display technique. Cancer Lett., 123, 7-14 (1998).
4. HEDINGER, C., WILLIAMS, E.D. and SOBIN, L.H., The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer, 63, 908-911 (1989).
5. HERTERVIG, E., NILSSON, A., NYBERG, L. and DUAN, R.-D., Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer, 79, 448-453 (1997).
6. KIM, M.-Y., LINARDIC, C., OBEID, L. and HANNUN, Y., Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and γ-interferon. J. biol. Chem., 266, 484-489 (1991).
7. KIMURA, T., OKAJIMA, F., KIKUCHI, T., KUWABARA, A., TOMURA, H., SHO, K., KOBAYASHI, I. and KONDO, Y., Inhibition of TSH-induced hydrogen-peroxide production by TNF-α through a sphingomyelinase signaling pathway. Amer. J. Physiol., 273, E638-E643 (1997).
8. KOCH, J., GARTNER, S., LI, C.-M., QUINTERN, L.E., BERNARDO, K., LEVRAN, O., SCHNABEL, D., DESNICK, R.J., SCHUCHMAN, E.H. and SANDHOFF, K., Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. J. biol. Chem., 271, 33110-33115 (1996).
9. KOLESNICK, R.N., 1,2-diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3 pituitary cells. J. biol. Chem., 262, 16759-16762 (1987).
10. LIANG, P. and PARDEE, A.B., Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-971 (1992).
11. LISCOVITCH, M. and CANTLEY, L.C., Lipid second messengers. Cell, 77, 329-334 (1994).
12. MATUOKA, K., SHIBATA, M., YAMAKAWA, A. and TAKENAWA, T., Cloning of ASH, a ubiquitous protein composed of one src homology region (SH) 2 and two SH3 domains, from human and rat cDNA libraries. Proc. nat. Acad. Sci. (Wash.), 89, 9015-9019 (1992).
13. MORI, K., STONE, S., BRAVERMAN, L.E. and DEVITO, W.J., Effects of ceramide and protein kinase C on the regulation of type I 5′-deiodinase in FRTL-5 rat thyroid cells. Endocrinology, 137, 4994-4999 (1996).
14. OBEID, L.M., LINARDIC, C.M., KAROLAK, L.A. and HANNUN, Y.A., Programmed cell death induced by ceramide. Science, 259, 1769-1771 (1993).
15. 2+ system in FRTL-5 cells: possible involvement of guanosine triphosphate-binding proteins in the lipid signaling. Endocrinology, 138, 220-229 (1997).
16. OKAZAKI, T., BELL, R.M. and HANNUN, Y.A., Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J. biol. Chem., 264, 19076-19080 (1989).
17. 2 regulate type-I deiodinase expression in FRTL-5 cells. Thyroid, 7, 647-654 (1997).
18. - symporter messenger ribonucleic-acid levels in FRTL-5 cells. Endocrinology, 139, 703-712 (1998).
19. SALESIOTIS, A.N., WANG, C.K., WANG, C.D., BURGER, A., LI, H. and SETH, A., Identification of novel genes from stomach cancer cell lines by differential display. Cancer Lett., 91, 47-54 (1995).
20. SLIFE, C.W., WANG, E., HUNTER, R., WANG, S., BURGESS, C., LIOTTA, D.C. and MERRILL, A.H. JR., Free sphingosine formation from endogenous substrates by a liver plasma membrane system with a divalent cation dependence and a neutral pH optimum. J. biol. Chem., 264, 10371-10377 (1989).
21. TAKANO, T., MATSUZUKA, F., SUMIZAKI, H., KUMA, K. and AMINO, N., Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma. Cancer Res., 57, 3792-3797 (1997).
22. + exchange in thyroid FRTL-5 cells. Amer. J. Physiol., 272, C1052-C1057 (1997).
23. TORNQUIST, K., SAARINEN, P., VAINIO, M. and AHLSTROM, M., Sphingosine 1-phosphate mobilizes sequestered calcium, activates calcium entry, and stimulates deoxyribonucleic acid synthesis in thyroid FRTL-5 cells. Endocrinology, 138, 4049-4057 (1997).